
GSK Recalls Zovirax IV Infusion over Glass-Like Particles, NAFDAC Warns Public
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert regarding the voluntary recall of a batch of Zovirax IV Infusion 250mg by pharmaceutical giant GlaxoSmithKline (GSK) Limited due to potential quality defects. In a statement titled Public Alert No. 09/2025, NAFDAC said the recall was initiated after the…